We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Insoluble Cellular Prion Protein and Other Neurodegeneration-Related Protein Aggregates in the Brain of Asymptomatic Individuals

    The pathological detergent-insoluble prion protein (PrPSc) is derived from its normal detergent-soluble cellular form (PrPC) through a structural...
    Wen-Quan Zou in Prions and Diseases
    Chapter 2023
  2. Mechanism of Insoluble Aggregate Formation in a Reconstituted Solution of Spray-Dried Protein Powder

    Background

    Spray-drying is considered a promising alternative drying method to lyophilization (freeze-drying) for therapeutic proteins. Particle...

    Yeqing Tao, Yuan Chen, ... Darryl Davis in Pharmaceutical Research
    Article Open access 02 May 2023
  3. Viral vector gene delivery of the novel chaperone protein SRCP1 to modify insoluble protein in in vitro and in vivo models of ALS

    Protein misfolding and aggregation are shared features of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), and protein...

    Ian W. Luecke, Gloria Lin, ... Allison D. Ebert in Gene Therapy
    Article Open access 08 July 2021
  4. Acute phase response following pulmonary exposure to soluble and insoluble metal oxide nanomaterials in mice

    Background

    Acute phase response (APR) is characterized by a change in concentration of different proteins, including C-reactive protein and serum...

    Claudia Torero Gutierrez, Charis Loizides, ... Ulla Vogel in Particle and Fibre Toxicology
    Article Open access 17 January 2023
  5. Protein Ubiquitination Assay

    Ubiquitin, a 76-amino acid protein which could covalently bind to a target protein, is catalyzed by an enzymatic cascade comprising of ATP-dependent...
    ** Wei, Rui Liang, Fan Pan in Regulatory T-Cells
    Protocol 2023
  6. TurboID-Based Proximity Labeling: A Method to Decipher Protein–Protein Interactions in Plants

    Proteins form complex networks through interaction to drive biological processes. Thus, dissecting protein–protein interactions (PPIs) is essential...
    Yuanyuan Li, Yongliang Zhang, Savithramma P. Dinesh-Kumar in Plant-Virus Interactions
    Protocol 2024
  7. Protein citrullination marks myelin protein aggregation and disease progression in mouse ALS models

    Increased protein citrullination (PC) and dysregulated protein arginine deiminase (PAD) activity have been observed in several neurodegenerative...

    Issa O. Yusuf, Tao Qiao, ... Zuoshang Xu in Acta Neuropathologica Communications
    Article Open access 08 September 2022
  8. Brain clearance of protein aggregates: a close-up on astrocytes

    Protein misfolding and accumulation defines a prevailing feature of many neurodegenerative disorders, finally resulting in the formation of toxic...

    Veronica Giusti, Gurkirat Kaur, ... Laura Civiero in Molecular Neurodegeneration
    Article Open access 16 January 2024
  9. Progress in mass spectrometry approaches to profiling protein–protein interactions in the studies of the innate immune system

    Understanding protein–protein interactions (PPIs) is pivotal for deciphering the intricacies of biological processes. Dysregulation of PPIs underlies...

    Doeun Kim, Aleksandra Nita-Lazar in Journal of Proteins and Proteomics
    Article Open access 28 June 2024
  10. Disease-Associated Q159X Mutant Prion Protein Is Sufficient to Cause Fatal Degenerative Disease in Mice

    PRNP Q160X is one of the five dominantly inheritable nonsense mutations causing familial prion diseases. Till now, it remains unclear how this type...

    Yan Zhang, Runchuan Yan, ... Jiyan Ma in Molecular Neurobiology
    Article 14 May 2024
  11. Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells

    Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disease affecting motor neurons. Pathological forms of Tar-DNA binding protein-43...

    Sonam Parakh, Emma R. Perri, ... Julie D. Atkin in NeuroMolecular Medicine
    Article Open access 11 June 2024
  12. In Situ Proximity Ligation Assay to Visualize Protein–Protein Interactions in Tumor Specimens

    Protein–protein interactions (PPI) are the basis of various biological phenomena, such as intracellular signal transduction, gene transcription, and...
    Yasuhiro Miki, Erina Iwabuchi, Takashi Suzuki in Cancer Systems and Integrative Biology
    Protocol 2023
  13. Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity

    A C9orf72 repeat expansion is the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis. One of the suggested...

    Annelies Quaegebeur, Idoia Glaria, ... Adrian M. Isaacs in Acta Neuropathologica Communications
    Article Open access 09 November 2020
  14. Assessing Protein Expression in Patient-Derived Xenografts Using Western Blotting

    The use of patient-derived xenografts (PDXs) in cancer research is increasing due to their ability to closely mimic the features of patient tumors....
    Bruna Rossi Herling, Moore Zhe Chen, Victoria M. McLeod in Patient-Derived Xenografts
    Protocol 2024
  15. Analysis of Pancreatic Acinar Protein Solubility in Autophagy-Deficient Mice

    Autophagy of the endoplasmic reticulum, or ER-phagy, maintains the homeostasis of the secretory pathway. This is particularly prominent in...
    Matthew Smith, Carla Salomo-Coll, ... Simon Wilkinson in Autophagy and Cancer
    Protocol 2022
  16. Autoantibody Profiling Using Human Autoantigen Protein Array and AlphaScreen

    Autoantibodies that recognize self-antigens are believed to have a close relationship with diseases such as autoimmune diseases, cancer, and...
    Hiroyuki Takeda in Rheumatoid Arthritis
    Protocol 2024
  17. Stability and Characterization of Protein- and Nucleotide-Based Therapeutics

    Throughout the development process of protein or nucleotide-based therapeutics, a broad array of analytical techniques is applied on a routine basis...
    Atanas V. Koulov in Pharmaceutical Biotechnology
    Chapter 2024
  18. Single-domain antibody-based protein degrader for synucleinopathies

    Synucleinopathies are a group of neurodegenerative diseases characterized by the accumulation of α-synuclein (α-syn) in the brain, leading to motor...

    Yixiang Jiang, Yan Lin, ... Einar M. Sigurdsson in Molecular Neurodegeneration
    Article Open access 31 May 2024
  19. Reconstruction of Protein/Liposome Complex

    Most ion channels and receptors are distributed in cell membranes and are known as membrane proteins. These membrane proteins are folded in the cell...
    Yasuyuki Suzuki in Rheumatoid Arthritis
    Protocol 2024
  20. Isolation and Detection of Pathological Tau Species in a Tauopathy Mouse Model

    Tau protein in Alzheimer’s disease (AD) and tauopathies becomes insoluble due to hyperphosphorylation, conformational alterations, and aggregation....
    Abhay Kumar Singh, Karthikeyan Selvarasu, Siva Sundara Kumar Durairajan in Neuroprotection
    Protocol 2024
Did you find what you were looking for? Share feedback.